Similar articles for PMID: 24637682

Year	Number of Results
1994	2
1997	1
2001	1
2003	3
2004	3
2005	5
2006	4
2007	7
2008	12
2009	11
2010	3
2011	7
2012	10
2013	10
2014	11
2015	3
2016	2
2017	5
2018	8
2019	4
2020	1
2021	6
2022	1
2023	2
2024	0

1

Liposome encapsulation of ciprofloxacin improves protection against highly virulent Francisella tularensis strain Schu S4.

Hamblin KA, Armstrong SJ, Barnes KB, Davies C, Wong JP, Blanchard JD, Harding SV, Simpson AJ, Atkins HS. Hamblin KA, et al. Antimicrob Agents Chemother. 2014 Jun;58(6):3053-9. doi: 10.1128/AAC.02555-13. Epub 2014 Mar 17. Antimicrob Agents Chemother. 2014. PMID: 24637682 Free PMC article.

2

The potential of liposome-encapsulated ciprofloxacin as a tularemia therapy.

Hamblin KA, Wong JP, Blanchard JD, Atkins HS. Hamblin KA, et al. Front Cell Infect Microbiol. 2014 Jun 18;4:79. doi: 10.3389/fcimb.2014.00079. eCollection 2014. Front Cell Infect Microbiol. 2014. PMID: 24995163 Free PMC article. Review.

3

Differential ability of novel attenuated targeted deletion mutants of Francisella tularensis subspecies tularensis strain SCHU S4 to protect mice against aerosol challenge with virulent bacteria: effects of host background and route of immunization.

Conlan JW, Shen H, Golovliov I, Zingmark C, Oyston PC, Chen W, House RV, Sjöstedt A. Conlan JW, et al. Vaccine. 2010 Feb 17;28(7):1824-31. doi: 10.1016/j.vaccine.2009.12.001. Epub 2009 Dec 16. Vaccine. 2010. PMID: 20018266 Free PMC article.

4

Live attenuated mutants of Francisella tularensis protect rabbits against aerosol challenge with a virulent type A strain.

Reed DS, Smith LP, Cole KS, Santiago AE, Mann BJ, Barry EM. Reed DS, et al. Infect Immun. 2014 May;82(5):2098-105. doi: 10.1128/IAI.01498-14. Epub 2014 Mar 10. Infect Immun. 2014. PMID: 24614653 Free PMC article.

5

Characterization of Inner and Outer Membrane Proteins from Francisella tularensis Strains LVS and Schu S4 and Identification of Potential Subunit Vaccine Candidates.

Post DMB, Slütter B, Schilling B, Chande AT, Rasmussen JA, Jones BD, D'Souza AK, Reinders LM, Harty JT, Gibson BW, Apicella MA. Post DMB, et al. mBio. 2017 Oct 10;8(5):e01592-17. doi: 10.1128/mBio.01592-17. mBio. 2017. PMID: 29018123 Free PMC article.

6

A Francisella tularensis Schu S4 purine auxotroph is highly attenuated in mice but offers limited protection against homologous intranasal challenge.

Pechous RD, McCarthy TR, Mohapatra NP, Soni S, Penoske RM, Salzman NH, Frank DW, Gunn JS, Zahrt TC. Pechous RD, et al. PLoS One. 2008 Jun 25;3(6):e2487. doi: 10.1371/journal.pone.0002487. PLoS One. 2008. PMID: 18575611 Free PMC article.

7

Live Attenuated Tularemia Vaccines for Protection Against Respiratory Challenge With Virulent F. tularensis subsp. tularensis.

Jia Q, Horwitz MA. Jia Q, et al. Front Cell Infect Microbiol. 2018 May 15;8:154. doi: 10.3389/fcimb.2018.00154. eCollection 2018. Front Cell Infect Microbiol. 2018. PMID: 29868510 Free PMC article. Review.

8

Novel catanionic surfactant vesicle vaccines protect against Francisella tularensis LVS and confer significant partial protection against F. tularensis Schu S4 strain.

Richard K, Mann BJ, Stocker L, Barry EM, Qin A, Cole LE, Hurley MT, Ernst RK, Michalek SM, Stein DC, Deshong P, Vogel SN. Richard K, et al. Clin Vaccine Immunol. 2014 Feb;21(2):212-26. doi: 10.1128/CVI.00738-13. Epub 2013 Dec 18. Clin Vaccine Immunol. 2014. PMID: 24351755 Free PMC article.

9

A ΔclpB mutant of Francisella tularensis subspecies holarctica strain, FSC200, is a more effective live vaccine than F. tularensis LVS in a mouse respiratory challenge model of tularemia.

Golovliov I, Twine SM, Shen H, Sjostedt A, Conlan W. Golovliov I, et al. PLoS One. 2013 Nov 13;8(11):e78671. doi: 10.1371/journal.pone.0078671. eCollection 2013. PLoS One. 2013. PMID: 24236032 Free PMC article.

10

Aerosol-, but not intradermal-immunization with the live vaccine strain of Francisella tularensis protects mice against subsequent aerosol challenge with a highly virulent type A strain of the pathogen by an alphabeta T cell- and interferon gamma- dependent mechanism.

Wayne Conlan J, Shen H, Kuolee R, Zhao X, Chen W. Wayne Conlan J, et al. Vaccine. 2005 Mar 31;23(19):2477-85. doi: 10.1016/j.vaccine.2004.10.034. Vaccine. 2005. PMID: 15752834

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

113 results

Results by year